Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.
about
TRIPS, the Doha Declaration and increasing access to medicines: policy options for GhanaImproving access to medicines in poor countries: the role of universities.The silent epidemic of exclusive university licensing policies on compounds for neglected diseases and beyond.Enhancing medicine price transparency through price information mechanisms.Closing the access gap for health innovations: an open licensing proposal for universitiesA proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement
P2860
Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pharmaceutical arbitrage: bala ...... nal prescription drug markets.
@en
Pharmaceutical arbitrage: bala ...... nal prescription drug markets.
@nl
type
label
Pharmaceutical arbitrage: bala ...... nal prescription drug markets.
@en
Pharmaceutical arbitrage: bala ...... nal prescription drug markets.
@nl
prefLabel
Pharmaceutical arbitrage: bala ...... nal prescription drug markets.
@en
Pharmaceutical arbitrage: bala ...... nal prescription drug markets.
@nl
P1476
Pharmaceutical arbitrage: bala ...... onal prescription drug markets
@en
P2093
Kevin Outterson
P304
P577
2005-01-01T00:00:00Z